Ratings
0
Nobody has rated this yet. Be the first!
Works
3
Regorafenib for patients with previously untreated metastatic or unresectable renal-cell carcinoma: a single-group phase 2 trial.
EphB4 expression and biological significance in prostate cancer
Survival analysis of genome-wide gene expression profiles of prostate cancers identifies new prognostic targets of disease relapse.
